Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 4

1(50.0%)

2Total

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05292404Phase 4Recruiting

Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction

Role: collaborator

NCT06099028Completed

Heart Failure Treatment Pattern Analysis of HF Patients in HF Centers and Non-HF Centers in China

Role: collaborator

NCT04015843Unknown

Compliance of Blood Pressure and Lipid in Hypertensive Patients Under the Management of Hospitals at Different Levels

Role: lead

NCT04014972Unknown

Clinical Features, Treatment Mode and Health Outcomes of Chest Pain Patients in China (CHANGE)

Role: lead

NCT03931200Completed

Demographic and Clinical Characteristics, Treatment Patterns and Clinical Outcomes of Heart Failure Patients in China

Role: lead

NCT03527563Not ApplicableUnknown

Study on Internet Medical Models for the Management of Patients With Hypertension in China

Role: lead

NCT03691246Unknown

Research on Burden of Disease for Patients With Myocardial Infarction Combining Dyslipidemia in China

Role: lead

NCT03398954Unknown

a Prospective Pilot Study of Screening Out Rate and Clinical Management of Familial Hypercholesterolemia

Role: lead

All 8 trials loaded